1. Home
  2. ICD-10-PCS MS-DRG V43.0
  3. Procedure Codes in MS-DRG 017 - Autologous Bone Marrow Transplant Without CC/MCC

Procedure Codes in MS-DRG 017 - Autologous Bone Marrow Transplant Without CC/MCC

The Medicare Severity Diagnosis-Related Group (MS-DRG) is a patient classification system used to categorize hospital cases based on clinical similarity and expected resource use. MS-DRGs organize all possible principal diagnoses into mutually exclusive groups known as Major Diagnostic Categories (MDCs), which help determine reimbursement under the Medicare Inpatient Prospective Payment System.

This section lists the procedure codes included in MS-DRG V43.0: Autologous Bone Marrow Transplant without CC/MCC from October 1, 2025, through September 30, 2026.

MS-DRG: 017

MS-DRG Title: Autologous Bone Marrow Transplant without CC/MCC

MCD:

Relative Weight: 4.8383 Relative Weight
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Geometric LOS: 5.43 Geometric Length of Stay
The geometric mean length of stay (GMLOS) is used by Medicare to calculate the reimbursement for patients whose medical treatment takes a much longer or shorter time than average.

Arithmetic LOS: 8.30 Arithmetic Length of Stay
The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission.

  • 302 - Administration, Circulatory, Transfusion

    • 30233AZ - Transfusion of Embryonic Stem Cells into Peripheral Vein, Percutaneous Approach

    • 30233C0 - Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach

    • 30233G0 - Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach

    • 30233X0 - Transfusion of Autologous Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach

    • 30233Y0 - Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach

    • 30243AZ - Transfusion of Embryonic Stem Cells into Central Vein, Percutaneous Approach

    • 30243C0 - Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Percutaneous Approach

    • 30243G0 - Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach

    • 30243X0 - Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach

    • 30243Y0 - Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach

  • XW1 - New Technology, Anatomical Regions, Transfusion

    • XW1337A - Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10

    • XW133B8 - Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    • XW133F8 - Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    • XW133G8 - Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    • XW133H9 - Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9

    • XW133J8 - Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    • XW133SB - Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11

    • XW1437A - Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10

    • XW143B8 - Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

    • XW143F8 - Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8

    • XW143G8 - Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

    • XW143H9 - Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9

    • XW143J8 - Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

    • XW143SB - Transfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11